Document Detail


Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion.
MedLine Citation:
PMID:  16382379     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Plasma levels of brain natriuretic peptide (BNP) have been examined in studies on patients with persistent atrial fibrillation, both before and after electrical cardioversion. Studied patients often showed a comorbidity with congestive heart failure, which complicates interpretation of measured BNP values as a natriuretic peptide. The aim of this study was to examine plasma levels of N-terminal fragment pro-brain natriuretic peptide (NT-pro-BNP), which is the more stable but inactive cleavage product of pro-BNP in patients with atrial fibrillation, but normal left ventricular ejection fraction, before and after electrical cardioversion. PATIENTS AND METHODS: NT-pro-BNP plasma levels of 34 consecutive patients were measured before, shortly after and 11 days after electrical cardioversion. All patients showed a normal ejection fraction after echocardiographic or laevocardiographic criteria. RESULTS: At baseline, all patients showed elevated NT-pro-BNP compared to a healthy control group (1086 vs. 66.9 pg/ml, p<0.001). After a mean follow-up time of 11 days in patients with persistent restored sinusrhythm, NT-pro-BNP decreased from 1071 pg/ml at baseline to 300 pg/ml (p<0.001). In contrast, patients with recurrence of atrial fibrillation showed increased levels from 1570.5 pg/ml at baseline to 1991 pg/ml (p=0.13; n.s.). Recurrence of atrial fibrillation was independent from height of NT-pro-BNP levels at baseline (p=0.23). CONCLUSIONS: Atrial fibrillation in patients with a normal left ventricular ejection fraction is associated with elevated NT-pro-BNP plasma levels, which decrease when a persistent sinus-rhythm can be restored by electrical cardioversion. On the other hand, NT-pro-BNP seems to increase (n.s.) when recurrence of atrial fibrillation occurs. Finally, NT-pro-BNP is no valid predictor for long-term success of sinus-rhythm restoration by electrical cardioversion.
Authors:
D-I Shin; K Jaekel; Ph Schley; A Sause; M Müller; R Fueth; T Scheffold; H Guelker; M Horlitz
Related Documents :
12240549 - Anemia and elevated systemic levels of vascular endothelial growth factor (vegf).
20170489 - Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intox...
11754849 - Postoperative delirium and melatonin levels in elderly patients.
19926599 - Red cell distribution width: an inexpensive and powerful prognostic marker in heart fai...
21072029 - The role of b-type natriuretic peptide testing in patients with acute coronary syndromes.
18545069 - Nt-probnp reduction percentage during hospital stay predicts long-term mortality and re...
12920259 - Association of parental history of stroke with clinical parameters in patients with isc...
20609189 - Impact of serum apolipoprotein a-iv as a marker of cardiovascular disease in maintenanc...
6872269 - Skin thickness in patients with acromegaly and cushing's syndrome and response to treat...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Zeitschrift für Kardiologie     Volume:  94     ISSN:  0300-5860     ISO Abbreviation:  Z Kardiol     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2005-12-29     Completed Date:  2006-03-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0360430     Medline TA:  Z Kardiol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  795-800     Citation Subset:  IM    
Affiliation:
HELIOS-Klinikum Wuppertal, Universitätsklinikum der Universität Witten-Herdecke, Herzzentrum Kardiologie, Medizinische Klinik III, Arrenberger Str. 20, 42117, Wuppertal, Germany. dshin@wuppertal.helios-kliniken.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Atrial Fibrillation / blood*,  diagnosis,  therapy*
Electric Countershock / methods*
Female
Humans
Male
Middle Aged
Natriuretic Peptide, Brain / blood*
Peptide Fragments / blood*
Prognosis
Reproducibility of Results
Sensitivity and Specificity
Treatment Outcome
Chemical
Reg. No./Substance:
0/Peptide Fragments; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterat...
Next Document:  Experience with INR self-management: patient selection and complication rates.